{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:57:23Z","timestamp":1790675843117,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00108-026-02156-8","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:22:44Z","timestamp":1785226964000},"page":"1131-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digitalis bei Herzinsuffizienz\u00a0\u2013 willkommen zur\u00fcck?","Digitalis for heart failure: welcome back?"],"prefix":"10.1007","volume":"67","author":[{"given":"Udo","family":"Bavendiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2156_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/med\/9780198891628.003.0047","volume-title":"The ESC Textbook of Heart Failure","author":"U Bavendiek","year":"2023","unstructured":"Bavendiek\u00a0U, BJ\u00a0BJ (2023) Digitalis glycosides. In: Seferovi\u0107\u00a0P, AJSC\u00a0AJSC, Filippatos\u00a0G, Anker\u00a0S, Bauersachs\u00a0J, Rosano\u00a0G (Hrsg) The ESC Textbook of Heart Failure. Oxford University Press, S\u00a0505\u2013516 https:\/\/doi.org\/10.1093\/med\/9780198891628.003.0047"},{"key":"2156_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"Digitalis Investigation Group","year":"1997","unstructured":"Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525\u2013533. https:\/\/doi.org\/10.1056\/NEJM199702203360801","journal-title":"N Engl J Med"},{"key":"2156_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.289.7.871","volume":"289","author":"SS Rathore","year":"2003","unstructured":"Rathore\u00a0SS, Curtis\u00a0JP, Wang\u00a0Y et\u00a0al (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289:871\u2013878. https:\/\/doi.org\/10.1001\/jama.289.7.871","journal-title":"JAMA"},{"key":"2156_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jacc.2005.02.091","volume":"46","author":"KF Adams Jr","year":"2005","unstructured":"Adams\u00a0KF Jr, Patterson\u00a0JH, Gattis\u00a0WA et\u00a0al (2005) Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.  J Am Coll Cardiol 46:497\u2013504. https:\/\/doi.org\/10.1016\/j.jacc.2005.02.091","journal-title":"J Am Coll Cardiol"},{"key":"2156_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","volume":"15","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade\u00a0M, Patel\u00a0K, Filippatos\u00a0G et\u00a0al (2013) Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail 15:551\u2013559. https:\/\/doi.org\/10.1093\/eurjhf\/hft010","journal-title":"Eur J Heart Fail"},{"key":"2156_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/eurheartj\/ehs004","volume":"33","author":"D Castagno","year":"2012","unstructured":"Castagno\u00a0D, Petrie\u00a0MC, Claggett\u00a0B et\u00a0al (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. Eur Heart J 33:1137\u20131141. https:\/\/doi.org\/10.1093\/eurheartj\/ehs004","journal-title":"Eur Heart J"},{"key":"2156_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","volume":"114","author":"A Ahmed","year":"2006","unstructured":"Ahmed\u00a0A, Rich\u00a0MW, Fleg\u00a0JL et\u00a0al (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114:397\u2013403. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.628347","journal-title":"Circulation"},{"key":"2156_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ejhf.1160","volume":"20","author":"AH Abdul-Rahim","year":"2018","unstructured":"Abdul-Rahim\u00a0AH, Shen\u00a0L, Rush\u00a0CJ et\u00a0al (2018) Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Eur J Heart Fail 20:1139\u20131145. https:\/\/doi.org\/10.1002\/ejhf.1160","journal-title":"Eur J Heart Fail"},{"key":"2156_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1056\/NEJMoa2415471","volume":"393","author":"U Bavendiek","year":"2025","unstructured":"Bavendiek\u00a0U, Grosshennig\u00a0A, Schwab\u00a0J et\u00a0al (2025) Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 393:1155\u20131165. https:\/\/doi.org\/10.1056\/NEJMoa2415471","journal-title":"N Engl J Med"},{"key":"2156_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ejhf.1452","volume":"21","author":"U Bavendiek","year":"2019","unstructured":"Bavendiek\u00a0U, Berliner\u00a0D, Davila\u00a0LA et\u00a0al (2019) Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. Eur J Heart Fail 21:676\u2013684. https:\/\/doi.org\/10.1002\/ejhf.1452","journal-title":"Eur J Heart Fail"},{"key":"2156_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3575","author":"U Bavendiek","year":"2025","unstructured":"Bavendiek\u00a0U, Berliner\u00a0D, Thomas\u00a0NH et\u00a0al (2025) The DIGIT-HF trial: Key amendments of study design. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3575","journal-title":"Eur J Heart Fail"},{"key":"2156_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag379","author":"U Bavendiek","year":"2026","unstructured":"Bavendiek\u00a0U, Thomas\u00a0NH, Maier\u00a0LS et\u00a0al (2026) Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehag379","journal-title":"Eur Heart J"},{"key":"2156_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04406-6","author":"DJ van Veldhuisen","year":"2026","unstructured":"van Veldhuisen\u00a0DJ, Rienstra\u00a0M, Mosterd\u00a0A et\u00a0al (2026) Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial. Nat Med. https:\/\/doi.org\/10.1038\/s41591-026-04406-6","journal-title":"Nat Med"},{"key":"2156_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehag385","author":"P van der Meer","year":"2026","unstructured":"van der Meer\u00a0P, van Veldhuisen\u00a0DJ, Voordes\u00a0GHD et\u00a0al (2026) Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehag385","journal-title":"Eur Heart J"},{"key":"2156_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199307013290101","volume":"329","author":"M Packer","year":"1993","unstructured":"Packer\u00a0M, Gheorghiade\u00a0M, Young\u00a0JB et\u00a0al (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329:1\u20137. https:\/\/doi.org\/10.1056\/NEJM199307013290101","journal-title":"N Engl J Med"},{"key":"2156_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0735-1097(93)90403-n","volume":"22","author":"BF Uretsky","year":"1993","unstructured":"Uretsky\u00a0BF, Young\u00a0JB, Shahidi\u00a0FE et\u00a0al (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J\u00a0Am Coll Cardiol 22:955\u2013962. https:\/\/doi.org\/10.1016\/0735-1097(93)90403-n","journal-title":"J Am Coll Cardiol"},{"key":"2156_CR17","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2026.7886","volume":"335","author":"K Damman","year":"2026","unstructured":"Damman\u00a0K, van Veldhuisen\u00a0DJ, Bauersachs\u00a0J et\u00a0al (2026) Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis. JAMA 335:2029\u20132037. https:\/\/doi.org\/10.1001\/jama.2026.7886","journal-title":"JAMA"},{"key":"2156_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"D Kotecha","year":"2014","unstructured":"Kotecha\u00a0D, Holmes\u00a0J, Krum\u00a0H et\u00a0al (2014) Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384:2235\u20132243. https:\/\/doi.org\/10.1016\/S0140-6736(14)61373-8","journal-title":"Lancet"},{"key":"2156_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2009.03.019","volume":"206","author":"J Jagielska","year":"2009","unstructured":"Jagielska\u00a0J, Salguero\u00a0G, Schieffer\u00a0B et\u00a0al (2009) Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis. Atherosclerosis 206:390\u2013396. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.03.019","journal-title":"Atherosclerosis"},{"key":"2156_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00392-023-02199-z","volume":"112","author":"U Bavendiek","year":"2023","unstructured":"Bavendiek\u00a0U, Grosshennig\u00a0A, Schwab\u00a0J et\u00a0al (2023) Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial. Clin Res Cardiol 112:1096\u20131107. https:\/\/doi.org\/10.1007\/s00392-023-02199-z","journal-title":"Clin Res Cardiol"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-026-02156-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-026-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:09:41Z","timestamp":1790672981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-026-02156-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1007\/s00108-026-02156-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"23 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.\u00a0Bavendiek und J.\u00a0Bauersachs geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}